Bayer (BAYN.DE) Stock Price

Bayer Price

XETRA·CLOSED
45.22
​
Market closed

Bayer stock price

Access this data via the Eulerpool API

Bayer business model & stock analysis

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain.

Frequently asked questions about Bayer

The business model of Bayer AG is focused on the development, manufacturing, and sale of healthcare and agricultural products. As a global pharmaceutical and life sciences company, Bayer AG operates in various sectors such as Pharmaceuticals, Consumer Health, Crop Science, and Animal Health. With its innovative research and development, Bayer AG aims to improve people's lives through its products and solutions. By maintaining a diverse portfolio, strong market presence, and strategic partnerships, the company seeks to address global challenges and contribute to a sustainable future in the fields of healthcare and agriculture.

Bayer AG is primarily active in the pharmaceutical, consumer health, and agricultural industries.

The main competitors of Bayer AG in the market include companies like Johnson & Johnson, Novartis AG, and Sanofi. These companies are also prominent players in the healthcare and pharmaceutical sectors. Bayer AG, a leading life sciences company, competes with these global giants in the areas of pharmaceuticals, consumer health, and crop science. With its diversified portfolio and innovative solutions, Bayer AG strives to stay competitive and maintain market leadership in its various segments.

Bayer AG is a renowned German pharmaceutical and life sciences company with a rich history and strong background. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, Bayer initially focused on the production of synthetic dyes. Over time, it diversified its portfolio and entered the fields of healthcare, agriculture, and high-tech materials. Today, Bayer is globally recognized for its contributions to medicine, crop protection, and innovative materials. With a commitment to science and sustainability, Bayer continues to improve lives and address global challenges.

Bayer AG has achieved significant milestones throughout its history. Some notable achievements include the development of Aspirin, a widely recognized pain reliever, and the invention of the first oral contraceptive pill. The company also played a crucial role in introducing genetically modified crops, revolutionizing agriculture practices. Additionally, Bayer AG successfully completed the acquisition of Monsanto Company, a leading agricultural biotechnology company. With a rich history of innovation and successful business ventures, Bayer AG continues to make strides in the fields of healthcare, pharmaceuticals, and agriculture, solidifying its position as a global industry leader.

Bayer AG is primarily present in numerous countries and regions worldwide. As a global pharmaceutical and life sciences company, Bayer AG has established a strong presence across Europe, North America, Asia Pacific, and Latin America. Specifically, in Europe, the company has a significant presence in Germany, where its headquarters are located. Furthermore, Bayer AG has a substantial footprint in the United States, contributing to its strong presence in North America. The company's operations extend into key markets in China and other Asian countries as well. With its global reach, Bayer AG aims to serve patients and customers around the world with innovative solutions and products.

Bayer AG represents values of innovation, sustainability, and responsibility. As a global company, Bayer focuses on providing solutions that improve people's lives and contribute to societal progress. Their corporate philosophy emphasizes ethical behavior, fairness, and integrity in all business activities. Bayer is committed to scientific excellence and advances in areas such as healthcare, agriculture, and nutrition. They strive to create a more sustainable future by developing environmentally friendly products and reducing their ecological footprint. With a strong emphasis on research and development, Bayer AG aims to continuously drive growth and make a positive impact worldwide.

The Bayer share (BAYN.DE) is listed on 14 stock exchanges, including: NASDAQ (BAYZF), London (0P6S.L), SIX (Zürich) (BAYN.SW), XETRA (BAYN.DE), Frankfurt (BAYN.F), München (BAYN.MU), Stuttgart (BAYN.SG), Düsseldorf (BAYN.DU).

The Bayer AG is a German company that operates in various business sectors. The company is active in the chemical and pharmaceutical industry and offers a wide range of products and services. Pharma and Health One of Bayer's most well-known business sectors is pharma and health. The company produces a variety of medications used for treating diseases such as diabetes, cancer, cardiovascular diseases, and many more. The most well-known medications include the pain reliever Aspirin, the contraceptive Yaz, and the cancer medication Nexavar. Crop Science Another important business sector of Bayer is Crop Science. Bayer produces seeds and plant protection products for the agribusiness sector. The company offers a wide range of products for the cultivation of crops such as grains, vegetables, and fruits. The company also supports farmers in the efficient use of water and energy for sustainable agriculture. Bayer Crop Science is a key player in the global agricultural landscape. Consumer Health Bayer also has a Consumer Health business sector that offers a variety of products for health and personal care. The company produces medications for minor illnesses and diseases such as cold and flu, as well as self-care products such as pain ointments, antiseptics, skin creams, and vitamins. The most well-known products include Coppertone sunscreen and the pain reliever Aleve. Animal Health Bayer also utilizes its expertise in animal health by producing medications and services. This business sector focuses on the health and well-being of livestock and pets. The company has an extensive range of products for the treatment and prevention of disease-related risks in pets as well as livestock. Bayer also has various business sectors focusing on the production of chemicals, materials, and technologies for the production of plastics, paints, adhesives, high-tech products, and more. Overall, Bayer AG's business model is oriented towards strong diversification to minimize risks and seize opportunities in various markets. With a wide range of products and a strong presence in different regions, Bayer continuously generates a high volume of revenue through its strong research and development and is an important company for the German economy.

The revenue cannot currently be calculated for Bayer.

The profit cannot currently be calculated for Bayer.

The P/E ratio cannot be calculated for Bayer at the moment.

The P/S cannot be calculated for Bayer currently.

The Eulerpool Quality Score cannot be calculated for Bayer at the moment.

The ISIN of Bayer is DE000BAY0017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bayer is BAY001. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bayer is BAYN.DE. The ticker symbol is used to trade Bayer shares on the stock exchange.

Fair ValueTerminal
44.77 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bayer.de
Country
Currency
EUR
Initial public offering
—
ISIN
DE000BAY0017
Cusip
D0712D163
Sedol
5069211
Market capitalization
45.18 B EURLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
—
ROA (Return on Assets)
—
ROCE (Return on Capital Employed)
—
ROIC (Return on Invested Capital)
—
Gross Margin
—
EBIT Margin
—
Net Margin
—
EPS (Earnings Per Share)
—
Net Debt / EBIT
—
Debt/Equity
—
Last updated Oct 3, 2026, 2:25 PM

Bayer Ticker

BERLIN · BAYN.BEDÜSSELDORF · BAYN.DUFRANKFURT · BAYN.FHAMBURG · BAYN.HMLONDON · 0P6S.LMILAN · 1BAYN.MIMUNICH · BAYN.MUNASDAQ · BAYZFSIX · BAYN.SWSTUTTGART · BAYN.SGVIENNA · BAYN.VIWARSAW · BAY.WA

Bayer FIGI

BAYN:GR · BBG000BBWDG1BAYN:GF · BBG000BBWDT7BAYN:GD · BBG000BBWF12BAYN:GY · BBG000BBWF85BAYN:GS · BBG000BBWG29BAYN:GM · BBG000BBWH90BAYN:GB · BBG000BBWJ50BAYN:GI · BBG000BBWK02BAYN:GH · BBG000BBWKS2BAYN:SW · BBG000BBWS96BAYN:SE · BBG000BBWT49BAYZF:US · BBG000BX8VK5

All fundamentals and in-depth analysis of Bayer

Our stock analysis for Bayer stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.